Nyxoah SA (NYXH) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Neuronetics (STIM) has outperformed Nyxoah SA (NYXH) over the past year, losing 27.9% versus a loss of 77.9%. Over five years, STIM leads with a -56.0% price change compared with -94.7% for NYXH. Neuronetics is the larger company by market cap ($162.3 million vs $138.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NYXH | STIM |
|---|---|---|
| Share price | $1.36 | $2.13 |
| Market cap | $138.50M | $162.30M |
| 1-day change | +0.74% | -0.47% |
| YTD return | -70.65% | +55.07% |
| 1-year return | -77.87% | -27.95% |
| 5-year return | -94.71% | -55.97% |
| EPS (TTM) | $-2.56 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.88 | $3.44 |
| 52-week low | $1.26 | $0.80 |
| Distance from 52-week high | -80.22% | -38.08% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +208.82% | +169.95% |
| Average volume | 275.85K | 2.07M |
| Shares outstanding | 101.84M | 76.20M |
| Employees | 153 | 658 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STIM has outperformed NYXH by 49.9 percentage points over the past year.
About Nyxoah SA
NYXH stock →Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Health Care · Medical/Dental Instruments · 153 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 658 employees
NYXH vs STIM FAQ
Which is bigger, Nyxoah SA or Neuronetics?
Neuronetics (STIM) is larger, with a market capitalization of $162.30M compared with $138.50M for Nyxoah SA (NYXH).
Which stock has performed better over the past year, NYXH or STIM?
STIM returned -27.95% over the past 12 months, compared with -77.87% for NYXH (price return, excluding dividends). Past performance does not predict future results.
Are Nyxoah SA and Neuronetics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.